AMBEV S.A. vs Keurig Dr Pepper Inc., two Food & Beverage stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Keurig Dr Pepper sells coffee pods and sodas; Ambev sells beer across Latin America. The returns are not close: Ambev earns 18.01% on equity against KDP's thin 6.28%, and keeps a slightly wider 12.17% of revenue versus 10.81%. KDP carries real leverage at 0.88 net debt to equity where Ambev carries none, which helps explain KDP's low 1.56 times book against Ambev's 2.90. On earnings KDP is the dearer stock, 24.73 times against 16.59. Ambev also converts more to cash, a 7.72% free cash yield versus 3.47%. Similar market values, $50.4B and $45.5B, but Ambev is the cleaner, higher-returning balance sheet.
Comparison updated 2026-07-11.
| Metric | ABEV | KDP |
|---|---|---|
| Price | $3.07 | $31.67 |
| Market cap | $47.9B | $43.2B |
| Sector | Food & Beverage | Food & Beverage |
| Stage | Mature | Mature |
| P/E | 15.8 | 23.5 |
| P/B | 2.75 | 1.48 |
| P/S | 1.86 | 2.55 |
| EV/EBITDA | 9.7 | 18.7 |
| Revenue growth | +4.8% | +9.2% |
| Gross margin | 34.5% | 52.8% |
| Operating margin | 17.8% | 19.0% |
| Net margin | 12.2% | 10.8% |
| Return on equity | 18.0% | 6.3% |
| Return on assets | 11.0% | 2.5% |
| Return on invested capital | 20.8% | 4.9% |
| FCF yield | 8.1% | 3.7% |
| Dividend yield | — | 2.9% |
| Debt / equity | 0.00 | 0.88 |
| Current ratio | 0.96 | 2.31 |
| Altman Z (solvency) | 4.03 | 1.24 |
| Piotroski F (quality) | 8 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.